Methylene blue shows real anti-aging potential in the lab, but there’s no human evidence that it slows aging or extends life. Skin cells treated with it age more slowly in a dish. A single dose improved memory slightly in one small human study. But when the US National Institute on Aging tested it in mice, median lifespan didn’t change. Here’s what the research supports, what it doesn’t, and how to think about methylene blue as a longevity tool.
Key takeaways
- Methylene blue supports mitochondria, the parts of your cells that make energy, which is why it interests aging researchers
- In a 2017 lab study, it delayed aging in human skin cells and boosted elastin in 3D skin models
- One small 2016 human study found a single dose improved memory recall by about 7%
- In the NIA’s mouse lifespan program, it didn’t extend median lifespan in either sex
- Large Alzheimer’s trials of a methylene blue drug mostly failed their main goals
- No clinical trial has tested methylene blue for human aging, so anti-aging claims are still unproven
Why methylene blue is being studied for anti-aging
Methylene blue is one of the oldest synthetic drugs. Chemists first made it in 1876. Doctors have used it for malaria, a blood disorder called methemoglobinemia, and as a surgical dye. Today it’s FDA-approved for methemoglobinemia, and it’s having a second life in longevity medicine.
The interest comes from one property: methylene blue can carry electrons inside your mitochondria. Mitochondria tend to work less efficiently with age, which is part of what researchers call mitochondrial dysfunction. If a cheap, old drug could keep them running smoothly, it could in theory slow some effects of aging. That’s a reasonable idea to test. It just hasn’t been proven in people.
Explore longevity options: methylene blue · general longevity treatments · NAD+ injection
How methylene blue works in aging cells
In healthy cells, energy production runs along a chain of proteins in the mitochondria. With age, parts of that chain wear down. Electrons leak out and form reactive oxygen species, unstable molecules that damage cells. Scientists call this oxidative stress.
At low doses, methylene blue can pick up electrons and pass them along, partly bypassing damaged steps in the chain. In lab studies, this helps cells keep making energy while producing less oxidative damage. That makes it behave like an antioxidant, but one that works right where much of the damage starts.
The catch is dose. At higher doses, methylene blue can flip and start creating oxidative stress instead of reducing it. So “more” doesn’t mean “more anti-aging”.
What the anti-aging evidence actually shows
Here’s how the main claims hold up:
| Claim | Best evidence so far | Type of evidence | Verdict |
|---|---|---|---|
| Slows skin aging | Delayed aging markers in human skin cells and 3D skin models (2017) | Lab only | Promising, unproven in people |
| Sharpens memory | ~7% better memory recall after one dose in 26 adults (2016) | Small human study | Real but modest, short-term |
| Prevents dementia | Large Alzheimer’s trials of a related drug | Human trials | Mostly failed main goals |
| Extends lifespan | No change in median lifespan in NIA mouse program (2014) | Animal study | Not supported |
| Slows physical aging | No effect on age-related bone loss in mice (2024) | Animal study | Not supported |
Methylene blue for skin aging: promising lab results
The most-cited anti-aging study comes from the University of Maryland, published in Scientific Reports in 2017. Researchers treated skin cells from young and older donors (some over 80) with low doses of methylene blue for four weeks.
The results were striking for a lab study. Methylene blue lowered markers of cell aging and helped older cells grow again. It beat three other antioxidants tested side by side, including N-acetylcysteine and MitoQ. In 3D lab-grown skin, it increased elastin, improved hydration, and thickened the dermis. Scratch “wounds” in cell layers also closed faster.
But this was all in dishes and lab tissue, over a few weeks. No one has run a trial showing methylene blue creams reduce wrinkles in real people. And at higher concentrations, the tissue turned blue and cell survival dropped.
Methylene blue for brain aging and memory: small human studies
This is where human data exists, though it’s limited. In a 2016 randomized trial, 26 healthy adults aged 22 to 62 took a single dose of about 280 mg (roughly 4 mg/kg) or a placebo. Brain scans showed more activity in memory-related regions. Memory recall improved by about 7%.
That’s a genuine finding. But it was one dose, in a small group, measured over hours. It doesn’t show that regular use protects the aging brain. For more on the brain side, see how methylene blue may help with mood regulation and mental clarity.
The bigger test came from Alzheimer’s research. A methylene blue-based drug (LMTM, also called hydromethylthionine) went through several large trials. A 15-month phase 3 trial of 891 patients found no effect on thinking or daily function. The later LUCIDITY trial missed its main goal in 2022, though some follow-up analyses have looked more hopeful. If methylene blue can’t clearly slow Alzheimer’s, claims that it prevents normal brain aging are getting well ahead of the data.
Methylene blue and lifespan: the mouse test that matters
The strongest test of any “longevity drug” is whether it helps animals live longer. The National Institute on Aging’s Interventions Testing Program does exactly this. It runs careful, multi-site lifespan studies in genetically diverse mice.
Methylene blue was tested there in 2014. Median lifespan didn’t change in males or females. The only signal was a small 6% increase in maximum lifespan in females.
Compare that with rapamycin and acarbose, which both extended lifespan in the same program. Acarbose was even tested in the same 2014 study. If you’re choosing a longevity drug based on lifespan data, methylene blue isn’t near the top of the list. Our guide to rapamycin explains why it gets so much attention.
Methylene blue and physical aging: no effect on bone
A 2024 study in the journal Aging gave older mice methylene blue for 6 to 12 months to see if it would slow age-related bone loss. It didn’t. Bone density, bone structure and grip strength all declined just as much as in untreated mice. The authors concluded that methylene blue alone is “insufficient” to prevent bone loss with age.
Where the methylene blue hype comes from
Online, methylene blue gets called a “blue pill” for brain fog, energy and slowing aging. Supplement brands sell drops and lozenges labeled “pharmaceutical grade.” Most of these claims stretch early lab findings or personal anecdotes into promises about human aging.
The pattern is familiar in longevity marketing: a real mechanism (better mitochondrial function) becomes an implied outcome (you’ll age slower). The mechanism is interesting. The outcome hasn’t been shown.
The evidence gap: what we still don’t know
Before methylene blue could be called an anti-aging treatment, researchers would need answers to some basic questions:
- Does long-term, low-dose use improve any measure of healthy aging in people?
- What’s the best dose for long-term use, if one exists?
- What are the risks of taking it daily for years?
- Does it help people with normal aging, or only specific conditions?
Right now, no clinical trial has tested methylene blue for human aging. That’s not a reason to dismiss it. It’s a reason to treat it as experimental.
Is methylene blue safe for anti-aging use?
At low doses under medical supervision, methylene blue is generally well tolerated. But it has two serious risks. It can cause serotonin syndrome when combined with SSRIs and other antidepressants. It can also trigger dangerous red blood cell breakdown in people with G6PD deficiency. It’s not safe in pregnancy, and only pharmaceutical-grade products are suitable for people.
We cover the full safety picture in is methylene blue safe? What you need to know before trying it. For overdose warning signs, see signs you’re taking too much methylene blue.
Should you use methylene blue for anti-aging?
If you’re curious, it’s reasonable to try methylene blue as one experimental piece of a broader longevity plan, as long as you do it carefully. A sensible approach:
- Start with a provider review of your medications, especially any antidepressants, and your G6PD status
- Use pharmaceutical-grade product at a low, prescribed dose. See our guide to taking methylene blue drops orally
- Set realistic expectations. You might notice a difference in focus or energy, but there’s no evidence it slows aging itself
- Don’t skip the basics. Sleep, exercise, and controlling blood sugar and blood pressure have far stronger longevity evidence than any supplement
The bottom line on methylene blue and anti-aging
Methylene blue is a fascinating molecule with real effects on mitochondria, skin cells and short-term memory. But the evidence stops short of the claims. In the most rigorous mouse lifespan test, it didn’t extend median lifespan. Large dementia trials of a related drug mostly failed. And it hasn’t been tested for human aging at all. Treat it as an experimental tool, not a proven anti-aging treatment. If you use it, use it under medical supervision.
Curious whether methylene blue fits your longevity goals? Talk to a Heally provider about methylene blue.
FAQ
Does methylene blue slow aging?
There’s no human evidence that it does. Lab studies show it delays aging markers in skin cells and supports mitochondrial function. But no clinical trial has tested it for human aging, and it didn’t extend median lifespan in the NIA’s mouse lifespan program.
Can methylene blue extend lifespan?
Not based on current evidence. In the National Institute on Aging’s 2014 mouse study, methylene blue didn’t change median lifespan in males or females. It only produced a small 6% increase in maximum lifespan in females. Rapamycin and acarbose have much stronger lifespan data.
Does methylene blue help with skin aging?
In the lab, yes. A 2017 study found it delayed aging in human skin cells and increased elastin and hydration in 3D skin models. But it hasn’t been tested on real people’s skin in clinical trials, so its effect on wrinkles is unknown.
Does methylene blue improve memory?
One small 2016 study found a single dose of about 280 mg improved memory recall by about 7% in healthy adults. That’s a real but modest short-term effect. Large Alzheimer’s trials of a related drug mostly failed, so long-term brain benefits aren’t established.
Is methylene blue a good anti-aging supplement?
It’s experimental. It has interesting lab data but no proven anti-aging benefit in people, and it carries real risks with antidepressants and G6PD deficiency. If you try it, use pharmaceutical-grade methylene blue under medical supervision, alongside proven habits like exercise and good sleep.
How does methylene blue work in the body?
At low doses, methylene blue carries electrons inside mitochondria, helping cells make energy while producing fewer damaging reactive oxygen species. At high doses, this effect can reverse and increase oxidative stress, which is why dose matters so much.
Sources
- Xiong ZM, et al. “Anti-Aging Potentials of Methylene Blue for Human Skin Longevity.” Scientific Reports, 2017. nature.com
- Rodriguez P, et al. “Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain.” Radiology, 2016.
- Harrison DE, et al. “Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males.” Aging Cell, 2014. wiley.com
- “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.” Aging, 2024. aging-us.com
- Alzheimer’s Drug Discovery Foundation. “Methylene blue (and TRx0237): Cognitive Vitality for Researchers.” alzdiscovery.org
This article is for educational purposes only and is not a substitute for professional medical advice. Methylene blue is not FDA-approved for anti-aging, longevity or cognitive use. Do not combine it with antidepressants or other serotonergic medications, and talk to a licensed healthcare provider before trying it.
